VNRX-5022

· Venatorx Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VNRX-5022, covering 2019-02-08 to 2019-02-08. Get the full timeline:

Most recent: Clinical Trial Update: VNRX-5133 With VNRX-5022 in Subjects With Varying Degrees of Renal Impairment [Phase 1]